- Home
- Equipment
- usa california
- genomic editing
Show results for
Refine by
Genomic Editing Equipment Supplied In Usa California
10 equipment items found
Manufactured by:ASC Therapeutics based inMilpitas, CALIFORNIA (USA)
Genome editing technologies enables permanent modifications to the genome by harnessing the activities of certain enzymes (e.g. nucleases and integrase) and invoking DNA repair mechanisms at specific locations in the genome. As a therapeutic modality, genome editing can correct a defective gene, ...
by:Caribou Biosciences, Inc. based inBerkeley, CALIFORNIA (USA)
Our next-generation chRDNA genome-editing platform is the foundation for the development of differentiated allogeneic cell therapies. Our chRDNA technology enables multiple genome edits, including multiplex gene insertions, with a high degree of specificity and lower levels of off-target editing than first ...
Manufactured by:Metagenomi based inEmeryville, CALIFORNIA (USA)
Ultra-small nucleases to expand in vivo delivery options; Our ultra-small nucleases are highly efficient genome editing systems that have the potential for extensive therapeutic applications. We have prioritized finding systems to overcome the size constraints of ...
by:Caribou Biosciences, Inc. based inBerkeley, CALIFORNIA (USA)
We are developing differentiated, off-the-shelf CAR-T cell therapies, derived from healthy donor T cells, that are genome-edited to improve persistence of antitumor activity and potential therapeutic benefit. ...
Manufactured by:Metagenomi based inEmeryville, CALIFORNIA (USA)
Genomic replacements and insertions; Metagenomi’s RIGS make programmable genomic modifications that are encoded in RNA templates. Using RIGS we can achieve small edits (prime editing), as well as large edits. Our RIGS platform allows us to ...
Manufactured by:SBI System Biosciences, LLC based inPalo Alto, CALIFORNIA (USA)
Use this first-generation SBI EF1α-hspCas9 SmartNickase when you want to reduce off-target events, have transfectable cells, and prefer an intact vector. Conveniently deliver Cas9 Nickase and gRNA with a single vector. Reduce off-target activity. Drive Cas9 Nickase expression with the EF1α promoter, which provides medium expression levels in most cell types, including primary cells ...
Manufactured by:Indee Labs based inBerkeley, CALIFORNIA (USA)
Hydropore™ is a simple, scalable and efficient way to accelerate the discovery, development and manufacturing of gene-modified cell therapies (GMCTs) such as T cell immunotherapies. This novel, non-viral technology utilizes the power of microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene-editing complexes to immune cells in a matter of ...
Manufactured by:Agilent Technologies, Inc. based inSanta Clara, CALIFORNIA (USA)
The SureGuide gRNA Synthesis Kit is part of an integrated solution for in-vitro CRISPR/Cas research. Use this kit to generate high concentrations of gRNA, and combine with the SureGuide Cas9, or your own Cas9 protein, to clone complex genomic regions with high accuracy and specificity. The SureGuide gRNA kit shortens your time from planning to experiment, and reduces the cost of setting up your ...
Manufactured by:Agilent Technologies, Inc. based inSanta Clara, CALIFORNIA (USA)
The Cas9 endonuclease kit is part of an integrated solution for in-vitro CRISPR/Cas resesarch. Use this kit for in-vitro cloning of large genes or DNA fragments without the limitations imposed by common restriction enzymes or PCR fidelity. Allows cleavage of DNA at single and multiple locations based on a custom sequence of interest. Customizable endonuclease specificity, Higher specificity than ...
Manufactured by:Thermo Fisher Scientific based inWaltham, MASSACHUSETTS (USA)
Invitrogen TrueCut HiFi Cas9 Protein is a high fidelity CRISPR Cas9 protein variant engineered to demonstrate superior off-target profiles, while preserving maximum on-target editing efficiency. TrueCut HiFi Cas9 Protein is ideal for applications that are sensitive to off-target events and when more precise editing is ...
